Recro Pharma, an oral solid dose contract development and manufacturing organization (CDMO), has made several appointments to its management team and board of directors.  Recro named Jim Miller, a highly regarded CDMO industry thought leader, to its board of directors. Additionally, the company appointed Ryan Lake, who has more than 20 years of senior financial and life sciences experience, as chief financial officer, in late 2020.  These additions, along with the appointment of David Enloe as c...